|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kirkali Z, Chan T, Manoharan M, Algaba F,
Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM,
et al: Bladder cancer: Epidemiology, staging and grading, and
diagnosis. Urology. 66:4–34. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kamat AM, Hahn NM, Efstathiou JA, Lerner
SP, Malmström PU, Choi W, Guo CC, Lotan Y and Kassouf W: Bladder
cancer. Lancet. 388:2796–2810. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Babjuk M, Bohle A, Burger M, Tobisawa Y,
Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, et
al: EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of
the Bladder: Update 2016. Eur Urol. 71:447–461. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nishiyama H: Asia Consensus Statement on
NCCN Clinical Practice Guideline for bladder cancer. Jpn J Clin
Oncol. 48:3–6. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sylvester RJ: Natural history, recurrence,
and progression in superficial bladder cancer.
ScientificWorldJournal. 6:2617–2625. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sylvester RJ, Oosterlinck W, Holmang S,
Sydes MR, Birtle A, Gudjonsson S, De Nunzio C, Okamura K, Kaasinen
E, Solsona E, et al: Systematic review and individual patient data
meta-analysis of randomized trials comparing a single immediate
instillation of chemotherapy after transurethral resection with
transurethral resection alone in patients with stage pTa-pT1
urothelial carcinoma of the bladder: Which patients benefit from
the instillation? Eur Urol. 69:231–244. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kang M, Jeong CW, Kwak C, Kim HH and Ku
JH: Single, immediate postoperative instillation of chemotherapy in
non-muscle invasive bladder cancer: A systematic review and network
meta-analysis of randomized clinical trials using different drugs.
Oncotarget. 7:45479–45488. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Solsona E, Iborra I, Ricos JV, Monros JL,
Casanova J and Dumont R: Effectiveness of a single immediate
mitomycin C instillation in patients with low risk superficial
bladder cancer: Short and long-term followup. J Urol.
161:1120–1123. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tolley DA, Parmar MK, Grigor KM, Lallemand
G, Benyon LL, Fellows J, Freedman LS, Grigor KM, Hall RR, Hargreave
TB, et al: The effect of intravesical mitomycin C on recurrence of
newly diagnosed superficial bladder cancer: A further report with 7
years of follow up. J Urol. 155:1233–1238. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oosterlinck W, Kurth KH, Schroder F,
Bultinck J, Hammond B and Sylvester R: A prospective European
Organization for Research and Treatment of Cancer Genitourinary
Group randomized trial comparing transurethral resection followed
by a single intravesical instillation of epirubicin or water in
single stage Ta, T1 papillary carcinoma of the bladder. J Urol.
149:749–752. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Okamura K, Ono Y, Kinukawa T, Matsuura O,
Yamada S, Ando T, Fukatsu T, Ohno Y and Ohshima S; Nagoya
University Urological Oncology Group, : Randomized study of single
early instillation of (2'R)-4′-O-tetrahydropyranyl-doxorubicin for
a single superficial bladder carcinoma. Cancer. 94:2363–2368. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mao T, Zhang H, Cui J, Zhao Z, Jiao D and
Zhang W: The 980 nm diode laser treatment for non-muscle-invasive
bladder tumor with en bloc technique: Single-center experience.
World J Surg Oncol. 20:3242022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wendt-Nordahl G, Huckele S, Honeck P,
Alken P, Knoll T, Michel MS and Häcker A: 980-nm Diode laser: A
novel laser technology for vaporization of the prostate. Eur Urol.
52:1723–1728. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Magers MJ, Lopez-Beltran A, Montironi R,
Williamson SR, Kaimakliotis HZ and Cheng L: Staging of bladder
cancer. Histopathology. 74:112–134. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
De Cassai A, Boscolo A, Tonetti T, Ban I
and Ori C: Assignment of ASA-physical status relates to
anesthesiologists' experience: A survey-based national-study.
Korean J Anesthesiol. 72:53–59. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Varma M, Delahunt B and van der Kwast T:
Grading Noninvasive Bladder Cancer: World Health Organisation 1973
or 2004 May Be the Wrong Question. Eur Urol. 76:413–415. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu J, Wang C, Ouyang J, Sun J and Hu C:
Efficacy and Safety of transurethral laser surgery versus
transurethral resection for Non-Muscle-invasive bladder cancer: A
Meta-Analysis and systematic review. Urol Int. 104:810–823. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Engilbertsson H, Aaltonen KE, Bjornsson S,
Kristmundsson T, Patschan O, Rydén L and Gudjonsson S:
Transurethral bladder tumor resection can cause seeding of cancer
cells into the bloodstream. J Urol. 193:53–57. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liang H, Yang T, Wu K, He D and Fan J: En
bloc resection improves the identification of muscularis mucosae in
non-muscle invasive bladder cancer. World J Urol. 37:2677–2682.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Staehler G, Schmiedt E and Hofstetter A:
Destruction of bladder neoplasms by means of transurethral
neodym-YAG-laser coagulation. Helv Chir Acta. 45:307–311. 1978.(In
German). PubMed/NCBI
|
|
22
|
D'Souza N and Verma A: Holmium laser
transurethral resection of bladder tumor: Our experience. Urol Ann.
8:439–443. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kramer MW, Rassweiler JJ, Klein J, Martov
A, Baykov N, Lusuardi L, Janetschek G, Hurle R, Wolters M, Abbas M,
et al: En bloc resection of urothelium carcinoma of the bladder
(EBRUC): A European multicenter study to compare safety, efficacy,
and outcome of laser and electrical en bloc transurethral resection
of bladder tumor. World J Urol. 33:1937–1943. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xishuang S, Deyong Y, Xiangyu C, Tao J,
Quanlin L, Hongwei G, Jibin Y, Dongjun W, Zhongzhou H, Jianbo W, et
al: Comparing the safety and efficiency of conventional monopolar,
plasmakinetic, and holmium laser transurethral resection of primary
non-muscle invasive bladder cancer. J Endourol. 24:69–73. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen X, Liao J, Chen L, Qiu S, Mo C, Mao
X, Yang Y, Zhou S and Chen J: En bloc transurethral resection with
2-micron continuous-wave laser for primary non-muscle-invasive
bladder cancer: A randomized controlled trial. World J Urol.
33:989–995. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu H, Wu J, Xue S, Zhang Q, Ruan Y, Sun X
and Xia S: Comparison of the safety and efficacy of conventional
monopolar and 2-micron laser transurethral resection in the
management of multiple nonmuscle-invasive bladder cancer. J Int Med
Res. 41:984–992. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhong C, Guo S, Tang Y and Xia S: Clinical
observation on 2 micron laser for non-muscle-invasive bladder tumor
treatment: Single-center experience. World J Urol. 28:157–161.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu H, Ma J, Chen Z, Yang J, Yuan H, Wang
T, Liu J, Yang W and Ye Z: Safety and efficacy of en bloc
transurethral resection With 1.9 microm vela laser for treatment of
Non-Muscle-invasive bladder cancer. Urology. 113:246–250. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng B, Qiu X, Li H and Yang G: The
safety and efficacy of front-firing green-light laser endoscopic en
bloc photoselective vapo-enucleation of non-muscle-invasive bladder
cancer. Ther Clin Risk Manag. 13:983–988. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang D, Xue B, Zang Y, Liu X, Zhu J, Zhou
Y and Shan Y: Efficacy and safety of potassium-titanyl-phosphate
laser vaporization for clinically non-muscle invasive bladder
cancer. Urol J. 11:1258–1263. 2014.PubMed/NCBI
|
|
31
|
Tao W, Sun C, Yao Q, Fu K, Shan Y, Zhang
Y, Xue B and Yang D: The clinical study of en bloc transurethral
resection with 980 nm laser for treatment of primary non-muscle
invasive bladder cancer. J Xray Sci Technol. 28:563–571.
2020.PubMed/NCBI
|
|
32
|
Chen J, Zhao Y, Wang S, Jin X, Sun P,
Zhang L and Wang M: Green-light laser en bloc resection for primary
non-muscle-invasive bladder tumor versus transurethral
electroresection: A prospective, nonrandomized two-center trial
with 36-month follow-up. Lasers Surg Med. 48:859–865. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Migliari R, Buffardi A and Ghabin H:
Thulium laser endoscopic en bloc Enucleation of Nonmuscle-Invasive
bladder cancer. J Endourol. 29:1258–1262. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu Y, Guan W, Chen W, Xie C, Ouyang Y, Wu
Y and Liu C: Comparing the treatment outcomes of
potassium-titanyl-phosphate laser vaporization and transurethral
electroresection for primary nonmuscle-invasive bladder cancer: A
prospective, randomized study. Lasers Surg Med. 47:306–311. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kunimoto S, Miura K, Takahashi Y, Takeuchi
T and Umezawa H: Rapid uptake by cultured tumor cells and
intracellular behavior of 4′-O-tetrahydropyranyladriamycin. J
Antibiot (Tokyo). 36:312–317. 1983. View Article : Google Scholar : PubMed/NCBI
|
